Answers are grounded in this paper and cite their sources.
Systematic review reveals divergent neurological outcomes between anti-Yo degeneration and anti-NMDAR encephalitis in ovarian tumors, highlighting persistent deficits in cancer patients.
Paraneoplastic neurological syndromes are rare immune-mediated disorders that may represent the first clinical manifestation of an underlying tumor. This report describes a 58-year-old woman with rapidly progressive cerebellar dysfunction and anti-Yo antibodies in serum and cerebrospinal fluid. Definite PNS was diagnosed according to the PNS-Care Score criteria (score: 10/10). Oncological evaluation revealed FIGO IIIC high-grade serous ovarian carcinoma (HGSOC) with extensive peritoneal dissemination. Despite corticosteroids, cytoreductive surgery, and carboplatin–paclitaxel chemotherapy, neurological disability progressed, although tumor control was achieved. A PRISMA-guided review of PubMed and Scopus identified 33 studies of PNSs associated with ovarian tumors published between 2016 and 2026. Anti-NMDAR encephalitis, mainly associated with ovarian teratomas, generally showed favorable recovery, whereas anti-Yo-associated cerebellar degeneration, predominantly linked to epithelial ovarian malignancies, had poor neurological outcomes. Prompt antibody testing, oncological investigation, and multidisciplinary treatment are essential, although anti-Yo-associated neurological deficits may be irreversible.
No takes yet. Share an insight, caveat, or question.
Zahorowska et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: